What Is Known And Objective: Allogeneic stem cell transplantation patients are often on immunosuppression including calcineurin inhibitors post-transplant for prevention of graft-versus-host disease. Recent data suggested that addition of midostaurin, a FLT-3 mutant kinase inhibitor, maintenance can reduce risk of relapse by 46% at 18 months post-transplant.
Case Description: Patient is a post-allogenetic stem cell transplant patient started on midostaurin for maintenance therapy.
Importance: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors and often result in therapy discontinuation. Small studies suggest that acupuncture may decrease aromatase inhibitor-related joint symptoms.
Objective: To determine the effect of acupuncture in reducing aromatase inhibitor-related joint pain.